Fresenius Medical Care AG (FMS) Change in Receivables (2010 - 2025)

Fresenius Medical Care AG (FMS) has reported Change in Receivables for 16 consecutive years, with $114.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Receivables rose 255.84% year-over-year to $114.1 million; the TTM figure through Dec 2025 stood at $129.3 million (up 246.11% YoY), while the FY2025 annual figure was -$88.5 million, up 58.19% from the prior year.
• Change in Receivables came in at $114.1 million for Q4 2025 at Fresenius Medical Care AG, up from -$136.7 million in the prior quarter.
• The five-year high for Change in Receivables was $205.8 million in Q1 2021, with the low at -$136.7 million in Q3 2025.
• Average Change in Receivables over 5 years is $24.9 million, with a median of $26.0 million recorded in 2022.
• The largest YoY upside for Change in Receivables was 381.75% in 2022 against a maximum downside of 1296.73% in 2022.
• Year by year, Change in Receivables stood at $36.9 million in 2021, then surged by 381.75% to $177.6 million in 2022, then tumbled by 76.38% to $42.0 million in 2023, then dropped by 23.6% to $32.1 million in 2024, then surged by 255.84% to $114.1 million in 2025.
• According to Business Quant data, Change in Receivables over the past three periods registered $114.1 million, -$136.7 million, and $118.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.